264 related articles for article (PubMed ID: 10491535)
21. Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study.
Soffietti R; Nobile M; Rudà R; Borgognone M; Costanza A; Laguzzi E; Mutani R
Cancer; 2004 Feb; 100(4):807-13. PubMed ID: 14770438
[TBL] [Abstract][Full Text] [Related]
22. Phase II study of weekly carboplatin in pretreated adult malignant gliomas.
Villani V; Pace A; Vidiri A; Tanzilli A; Sperati F; Terrenato I; Mariantonia C; Casini B; Metro G; Maschio M; Tatiana K; Cognetti F; Fabi A
J Neurooncol; 2019 Aug; 144(1):211-216. PubMed ID: 31273578
[TBL] [Abstract][Full Text] [Related]
23. Carboplatin and etoposide for recurrent malignant glioma following surgical and radiotherapy failure: A clinical study conducted at the Northern Israel Oncology Center.
Stein ME; Kuten A; Drumea K; Goldsher D; Tzuk-Shina Z
J Surg Oncol; 1999 Jul; 71(3):167-70. PubMed ID: 10404133
[TBL] [Abstract][Full Text] [Related]
24. Intravenous carboplatin for recurrent gliomas. A dose-escalating phase II trial.
Prados MD; Warnick RE; Mack EE; Chandler KL; Rabbitt J; Page M; Malec M
Am J Clin Oncol; 1996 Dec; 19(6):609-12. PubMed ID: 8931682
[TBL] [Abstract][Full Text] [Related]
25. A phase II study of intravenous carboplatin for the treatment of recurrent gliomas.
Warnick RE; Prados MD; Mack EE; Chandler KL; Doz F; Rabbitt JE; Malec MK
J Neurooncol; 1994; 19(1):69-74. PubMed ID: 7815106
[TBL] [Abstract][Full Text] [Related]
26. Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer.
Choi NC; Herndon JE; Rosenman J; Carey RW; Chung CT; Bernard S; Leone L; Seagren S; Green M
J Clin Oncol; 1998 Nov; 16(11):3528-36. PubMed ID: 9817271
[TBL] [Abstract][Full Text] [Related]
27. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).
Gnekow AK; Kortmann RD; Pietsch T; Emser A
Klin Padiatr; 2004; 216(6):331-42. PubMed ID: 15565548
[TBL] [Abstract][Full Text] [Related]
28. Phase I/II trial of pyrazoloacridine and carboplatin in patients with recurrent glioma: a North Central Cancer Treatment Group trial.
Galanis E; Buckner JC; Maurer MJ; Reid JM; Kuffel MJ; Ames MM; Scheithauer BW; Hammack JE; Pipoly G; Kuross SA
Invest New Drugs; 2005 Oct; 23(5):495-503. PubMed ID: 16133802
[TBL] [Abstract][Full Text] [Related]
29. Pre-irradiation chemotherapy and hyperfractionated radiation therapy 66 Gy for children with brain stem tumors. A phase II study of the Pediatric Oncology Group, Protocol 8833.
Kretschmar CS; Tarbell NJ; Barnes PD; Krischer JP; Burger PC; Kun L
Cancer; 1993 Aug; 72(4):1404-13. PubMed ID: 8339231
[TBL] [Abstract][Full Text] [Related]
30. A detrimental effect of a combined chemotherapy-radiotherapy approach in children with diffuse intrinsic brain stem gliomas?
Freeman CR; Kepner J; Kun LE; Sanford RA; Kadota R; Mandell L; Friedman H
Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):561-4. PubMed ID: 10837936
[TBL] [Abstract][Full Text] [Related]
31. A phase I trial of concomitant chemoradiotherapy with cisplatin dose intensification and granulocyte-colony stimulating factor support for advanced malignancies of the chest.
Vokes EE; Haraf DJ; Drinkard LC; Hoffman PC; Ferguson MK; Vogelzang NJ; Watson S; Lane NJ; Golomb HM
Cancer Chemother Pharmacol; 1995; 35(4):304-12. PubMed ID: 7530173
[TBL] [Abstract][Full Text] [Related]
32. Activity and toxicity of carboplatin and iproplatin in relapsed high-grade glioma.
Twelves CJ; Ash CM; Miles DW; Thomas DG; Souhami RL
Cancer Chemother Pharmacol; 1991; 27(6):481-3. PubMed ID: 2013119
[TBL] [Abstract][Full Text] [Related]
33. Single agent carboplatin for pediatric low-grade glioma: A retrospective analysis shows equivalent efficacy to multiagent chemotherapy.
Dodgshun AJ; Maixner WJ; Heath JA; Sullivan MJ; Hansford JR
Int J Cancer; 2016 Jan; 138(2):481-8. PubMed ID: 26235348
[TBL] [Abstract][Full Text] [Related]
34. White matter changes are correlated significantly with radiation dose. Observations from a randomized dose-escalation trial for malignant glioma (Radiation Therapy Oncology Group 83-02).
Corn BW; Yousem DM; Scott CB; Rotman M; Asbell SO; Nelson DF; Martin L; Curran WJ
Cancer; 1994 Nov; 74(10):2828-35. PubMed ID: 7954244
[TBL] [Abstract][Full Text] [Related]
35. A phase II study of gefitinib and irradiation in children with newly diagnosed brainstem gliomas: a report from the Pediatric Brain Tumor Consortium.
Pollack IF; Stewart CF; Kocak M; Poussaint TY; Broniscer A; Banerjee A; Douglas JG; Kun LE; Boyett JM; Geyer JR
Neuro Oncol; 2011 Mar; 13(3):290-7. PubMed ID: 21292687
[TBL] [Abstract][Full Text] [Related]
36. Hyperfractionated radiation therapy for gliomas of the brainstem in children and in adults.
Shrieve DC; Wara WM; Edwards MS; Sneed PK; Prados MD; Cogen PH; Larson DA; Levin VA
Int J Radiat Oncol Biol Phys; 1992; 24(4):599-610. PubMed ID: 1429081
[TBL] [Abstract][Full Text] [Related]
37. Phase I study of weekly topotecan combined to concurrent external cranial irradiation in adults with glioblastoma multiforme of the brain.
Varveris H; Petinelli E; Stratakis J; Mazonakis M
Oncol Rep; 2008 Feb; 19(2):447-55. PubMed ID: 18202794
[TBL] [Abstract][Full Text] [Related]
38. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
39. Phase I trial using patupilone (epothilone B) and concurrent radiotherapy for central nervous system malignancies.
Fogh S; Machtay M; Werner-Wasik M; Curran WJ; Bonanni R; Axelrod R; Andrews D; Dicker AP
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1009-16. PubMed ID: 19879067
[TBL] [Abstract][Full Text] [Related]
40. Phase I evaluation of preirradiation chemotherapy with carmustine and cisplatin and accelerated radiation therapy in patients with high-grade gliomas.
Rajkumar SV; Buckner JC; Schomberg PJ; Pitot HC; Ingle JN; Cascino TL
Neurosurgery; 1999 Jan; 44(1):67-73. PubMed ID: 9894965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
